StockData
Edwards Lifesciences Corp logo

Edwards Lifesciences Corp

EWNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3060% above fair value
$103.88−1.35 (-1.28%)

Close on Nov 19, 2026Market cap $59.88BP/E 59.7Yield –

Edwards Lifesciences Intellectual Property Litigation & Settlement by Quarter

Intellectual Property Litigation & Settlement Expenses, Net ($M)

Edwards Lifesciences Intellectual Property Litigation & Settlement: -$12.7M in Q3 2026, down 114.0% from a year earlier.

Latest, Q3 2026
-12.7
Period ended Sep 30, 2026
Change on a year earlier
-114.0%
90.4 in Q3 2025
History
42 quarters
Since Q1 2016
Sources
37
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Filing (0001099800-26-000054) ↗

Reported in Form 10-K / Form 10-Q Special Charges Footnote.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIntellectual Property Litigation & Settlement Expenses, Net ($M)Year on yearSource
Q3 2026Sep 30, 2026-12.7-114.0%SEC Filing (0001099800-26-000054) ↗
Q2 2026Jun 30, 20266.30-59.4%SEC Filing (0001099800-26-000043) ↗
Q1 2026Mar 31, 202637.1+240.4%SEC Filing (0001099800-26-000026) ↗
Q4 2025Dec 31, 2025209+1,555.6%SEC Filing (0001099800-26-000009) ↗
Q3 2025Sep 30, 202590.4+737.0%SEC Filing (0001099800-26-000054) ↗
Q2 2025Jun 30, 202515.5+91.4%SEC Filing (0001099800-26-000043) ↗
Q1 2025Mar 31, 202510.9+22.5%SEC Filing (0001099800-26-000026) ↗
Q4 2024Dec 31, 202412.6+27.3%SEC Filing (0001099800-26-000009) ↗
Q3 2024Sep 30, 202410.8+390.9%SEC Filing (0001099800-25-000062) ↗
Q2 2024Jun 30, 20248.10-94.5%SEC Filing (0001099800-25-000048) ↗
Q1 2024Mar 31, 20248.90-79.5%SEC Filing (0001099800-25-000023) ↗
Q4 2023Dec 31, 20239.90–SEC Filing (0001099800-26-000009) ↗
Q3 2023Sep 30, 20232.20-191.7%SEC Filing (0001099800-24-000086) ↗
Q2 2023Jun 30, 2023148+2,324.6%SEC Filing (0001099800-24-000078) ↗
Q1 2023Mar 31, 202343.5+512.7%SEC Filing (0001099800-24-000039) ↗
Q3 2022Sep 30, 2022-2.40-151.1%SEC Filing (0001099800-23-000039) ↗

Cite this data

StockData. (2026). Edwards Lifesciences Intellectual Property Litigation & Settlement ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Edwards Lifesciences SEC filings and investor materials. https://stockdatahq.com/stocks/ew/kpis/res-litigation-exp

See every metric in the Edwards Lifesciences KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?